Statistical inferences for data from studies conducted with an aggregated multivariate outcome-dependent sample design. Read more about Statistical inferences for data from studies conducted with an aggregated multivariate outcome-dependent sample design.
Nine-year change in statistical design, profile, and success rates of Phase II oncology trials. Read more about Nine-year change in statistical design, profile, and success rates of Phase II oncology trials.
ICGOR: Fit Generalized Odds Rate Hazards Model with Interval Censored Data (R) Read more about ICGOR: Fit Generalized Odds Rate Hazards Model with Interval Censored Data (R)
Outcome-dependent sampling with interval-censored failure time data. Read more about Outcome-dependent sampling with interval-censored failure time data.
On Enrichment Strategies for Biomarker Stratified Clinical Trials. Read more about On Enrichment Strategies for Biomarker Stratified Clinical Trials.
Practical designs for Phase I combination studies in oncology. Read more about Practical designs for Phase I combination studies in oncology.
Using Structural Equation Modeling to Assess the Links between Tobacco Smoke Exposure, Volatile Organic Compounds, and Respiratory Function for Adolescents Aged 6 to 18 in the United States. Read more about Using Structural Equation Modeling to Assess the Links between Tobacco Smoke Exposure, Volatile Organic Compounds, and Respiratory Function for Adolescents Aged 6 to 18 in the United States.
Regression analysis for secondary response variable in a case-cohort study. Read more about Regression analysis for secondary response variable in a case-cohort study.
Phase II Trials for Heterogeneous Patient Populations with a Time-to-Event Endpoint. Read more about Phase II Trials for Heterogeneous Patient Populations with a Time-to-Event Endpoint.
DOUBLY ROBUST ESTIMATION OF OPTIMAL TREATMENT REGIMES FOR SURVIVAL DATA-WITH APPLICATION TO AN HIV/AIDS STUDY. Read more about DOUBLY ROBUST ESTIMATION OF OPTIMAL TREATMENT REGIMES FOR SURVIVAL DATA-WITH APPLICATION TO AN HIV/AIDS STUDY.
